Also from this source

You just read:

Dr. Fred Ueland, Markey Cancer Center, University of Kentucky Presents OVA1™ High Sensitivity Data at the 13th Annual International Gynecologic Cancer Society Meeting

News provided by

Vermillion, Inc.

Oct 25, 2010, 08:00 ET